Company / Current Liabilities
SELLAS Life Sciences Group, Inc. Current Liabilities History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$9.5M
FY2024
5-year range
$5.0M / $15.5M
FY2020-FY2024
Trend
-30.8%
vs FY2023
Sector context
#207 of 213
Health Care
What the data says
Among 213 Health Care companies, SELLAS Life Sciences Group, Inc. is in the top 3% for current liabilities. Current Liabilities has fluctuated over the past 10 years, ranging from $5M in FY2021 to $57M in FY2015.
Based on SEC 10-K filings.
$10M in FY2024 with a 5-year CAGR of +12.4%.
Improved from $16M to $10M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +24.0%
- 5-Year CAGR
- +12.4%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 213This company $9.5M Sector average $1.6B
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +12.4%, indicating consistent growth.
- In FY2024, current liabilities decreased 30.8% year-over-year.
- Ranks #207 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $9.5M | -30.8% |
| FY2023 | $13.7M | -11.5% |
| FY2022 | $15.5M | +211.4% |
| FY2021 | $5.0M | -59.6% |
| FY2020 | $12.3M | +133.2% |
| FY2019 | $5.3M | -11.4% |
| FY2018 | $6.0M | -75.7% |
| FY2017 | $24.6M | +326.7% |
| FY2016 | $5.8M | -89.9% |
| FY2015 | $57.1M | +109.6% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026